KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Revenue (2016 - 2025)

Thermo Fisher Scientific (TMO) has disclosed Revenue for 16 consecutive years, with -$317.0 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Revenue fell 102.91% year-over-year to -$317.0 million, compared with a TTM value of $31.2 billion through Dec 2024, down 27.28%, and an annual FY2025 reading of -$1.4 billion, down 2.09% over the prior year.
  • Revenue was -$317.0 million for Q4 2024 at Thermo Fisher Scientific, down from $10.6 billion in the prior quarter.
  • Across five years, Revenue topped out at $11.8 billion in Q2 2022 and bottomed at -$317.0 million in Q4 2024.
  • Average Revenue over 5 years is $9.5 billion, with a median of $10.6 billion recorded in 2020.
  • The sharpest move saw Revenue soared 59.0% in 2021, then plummeted 102.91% in 2024.
  • Year by year, Revenue stood at $10.6 billion in 2020, then grew by 1.44% to $10.7 billion in 2021, then increased by 6.99% to $11.5 billion in 2022, then dropped by 4.93% to $10.9 billion in 2023, then plummeted by 102.91% to -$317.0 million in 2024.
  • Business Quant data shows Revenue for TMO at -$317.0 million in Q4 2024, $10.6 billion in Q3 2024, and $10.5 billion in Q2 2024.